Endometrioid adenocarcinoma arising from endometriosis during 2 years of estrogen replacement therapy after total hysterectomy and bilateral salpingo-oophorectomy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 8, 2006, Pages 1019-1021

  Nomura, Seiji ^a,b   Suganuma, Takayasu ^a   Suzuki, Takahiro ^a   Ito, Tomomi ^a   Kajiyama, Hiroaki ^a   Okada, Mayumi ^a   Shibata, Kiyosumi ^a   Ino, Kazuhiko ^a   Kikkawa, Fumitaka ^a   Mizutani, Shigehiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Endometrioid adenocarcinoma; Endometriosis; Estrogen replacement therapy; Hysterectomy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CONJUGATED ESTROGEN; ESTROGEN; IRINOTECAN; MEDROXYPROGESTERONE ACETATE; PACLITAXEL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; ENDOMETRIUM CARCINOMA; ESTROGEN THERAPY; FEMALE; HISTOLOGY; HUMAN; HYSTERECTOMY; LIVER METASTASIS; PELVIS; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT DURATION; TUMOR BIOPSY;

ADULT; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; ESTROGEN REPLACEMENT THERAPY; FATAL OUTCOME; FEMALE; HUMANS; HYSTERECTOMY; OVARIECTOMY; UTERINE DISEASES;

EID: 33746377986     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340600609103     Document Type: Article

References (6)

1. Sampson JA. Endometrial carcinoma of the ovary, arising in endometrial tissue of that organ. Arch Surg. 1925;10:1-72.
2. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol. 1990;75:1023-8.
3. Gucer F, Pieber D, Arikan MG. Malignancy arising in extraovarian endometriosis during estrogen stimulation. Eur J Gynaecol Oncol. 1998;19:39-41.
4. Vignali M, Infantino M, Matrone R, Chiodo I, Somigliana E, Busacca M, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril. 2002;78:665-78.
5. Zanetta GM, Webb MJ, Li H, Keeney GL. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol. 2000;79:18-22.
6. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-33.